Previous 10 | Next 10 |
2024-06-16 07:19:35 ET Summary Sanofi's shares have not fully recovered since announcing a business strategy change in October 2023, focusing on R&D investments and on separating its consumer healthcare business unit. The company's immunology business, led by Dupixent and othe...
2024-06-14 17:13:58 ET More on Amgen Amgen Inc. (AMGN) Goldman Sachs 45th Annual Global Healthcare Conference Transcript Amgen Is A Fantastic Dividend Growth Stock With A Weight-Loss Wild Card Amgen Stock: Poised To Break Out (Technical Analysis) Amgen posts ...
FDA APPROVES BLINCYTO® (BLINATUMOMAB) IN CD19-POSITIVE PHILADELPHIA CHROMOSOME-NEGATIVE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL) IN THE CONSOLIDATION PHASE PR Newswire BLINCYTO ® Added to Multiphase Consolidation Chemotherapy Reduced Risk of Deat...
2024-06-14 10:24:55 ET Summary Structure Therapeutics Inc. shares surged over 50% on positive GSBR-1290 data, competing with other oral GLP-1R clinical rivals. However, GSBR-1290's efficacy at week 12 fell below Novo Nordisk's amycretin, but still competitive in the obesity treatm...
2024-06-13 14:03:52 ET Summary Contineum Therapeutics, Inc. PIPE-791 is being developed for the treatment of neuroinflammatory disorders like idiopathic pulmonary fibrosis and Progressive Multiple Sclerosis. The global idiopathic pulmonary fibrosis market size is projected to reac...
2024-06-12 12:33:43 ET More on Eli Lilly, Novo Nordisk, etc. Eli Lilly: The Road To Approval Of Donanemab Is Open Eli Lilly and Company (LLY) Goldman Sachs 45th Annual Global Healthcare Conference Is It Possible Eli Lilly Is Breaking Out To New All-Time Highs? ...
AMGEN TO PRESENT INNOVATIVE RHEUMATOLOGY RESEARCH AT EULAR 2024 PR Newswire Data Highlight Positive Outcomes in Uncontrolled Gout With KRYSTEXXA ® and Progress in Addressing Sjögren's Disease THOUSAND OAKS, Calif. , June 12, 2024...
2024-06-11 09:14:04 ET More on Viridian Therapeutics Viridian Therapeutics, Inc. (VRDN) Q1 2024 Earnings Call Transcript Viridian Therapeutics, Inc. 2024 Q1 - Results - Earnings Call Presentation Seeking Alpha’s Quant Rating on Viridian Therapeutics Hi...
2024-06-10 11:48:01 ET Amgen Inc. (AMGN) Goldman Sachs 45th Annual Global Healthcare Conference June 10, 2024 09:20 A.M. ET Company Participants James E. Bradner – EVP of Research and Development & Chief Scientific Officer Peter H. Griffith – EVP &a...
2024-06-10 09:00:00 ET Summary Invesco Dow Jones Industrial Average Dividend ETF holds the 28 stocks of the Dow Jones paying a dividend, weighted based on yields. DJD is better balanced across sectors than its parent index but is quite concentrated in its top holdings. DJD loo...
News, Short Squeeze, Breakout and More Instantly...
2024-06-29 08:45:00 ET If there is one thing income investors like more than regular dividend payouts, it's regular and growing dividend payouts. Not every corporation can offer that, of course. Some will eventually suspend their dividend programs or, at the very least, decrease their p...
PALM BEACH, Fla., June 20, 2024 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - Pancreatic cancer is among the most frequently diagnosed and the seventh leading cause of cancer death globally. Pancreatic cancer becomes more common in the Western world. The prevalence rate of panc...
2024-06-20 08:15:00 ET Amgen (NASDAQ: AMGN) is a top drugmaker whose shares have risen by more than 70% in five years, which is a bit shy of the S&P 500 's 90% gain over that stretch. With some promising products in its pipeline, the future does looks encouraging. However, s...